 |
Meropenem |
|---|---|
| Trade Name | Merrem Iv |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2000-04-27 00:00:00 |
| Sponsor | AstraZeneca Pharmaceuticals;1800 Concord Pike, PO Box 15437;Wilmington, Delaware, 19850 |
Related Access Program
| |
Meropenem |
|---|---|
| Trade Name | Merrem Iv |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2000-04-27 00:00:00 |
| Sponsor | AstraZeneca Pharmaceuticals;1800 Concord Pike, PO Box 15437;Wilmington, Delaware, 19850 |